What We're Reading: Page 5
Industry reads hand-picked by our editors
Dec 15, 2025
Dec 12, 2025
Dec 11, 2025
Dec 10, 2025
-
The Financial Times
Biotech rally mints huge profits for hedge funds
-
The New York Times
FDA Expands Covid Vaccine Inquiry to Adult Deaths
-
Endpoints
Eli Lilly will be ‘aggressive’ in spending GLP-1 money, top dealmaker Van Naarden says
-
Los Angeles Times
How a rare drug made from scientists’ blood saves babies from botulism
Dec 09, 2025
Dec 08, 2025
-
CBS News
Appointment of controversial FDA official rocking agency like “an atom bomb,” scientists there say
-
The Atlantic
The Rarest of All Diseases Are Becoming Treatable
-
Forbes
Why Mark Cuban’s Drug Cost Message Resonates: It’s Simple
-
The Boston Globe
In Massachusetts visit, Trump’s NIH chief defends move to prioritize funding research in places like Iowa, Nebraska
Dec 05, 2025
-
The New York Times
Kennedy’s Methodical 2-Decade Quest to Dismantle Vaccine Policy
-
MIT Technology Review
The ads that sell the sizzle of genetic trait discrimination
-
Science
To boost research, states are building their own AI-ready supercomputers
Previous
